Transformative RNA Based Treatments
-Antisense Oligonucleotides-
Targeting the Root Cause of Pulmonary Diseases
Our innovative RNA based therapies, based on Antisense Oligonucleotides (ASOs), restore and modify protein functionality, addressing untreatable pulmonary diseases.
Transformative RNA-Based Treatments
SpliSense is a clinical stage company developing transformative RNA-based treatments for unmet needs relating to diverse pulmonary diseases. Our treatment is based on clinically validated Antisense Oligonucleotide (ASO) technology, delivered non-invasively by inhalation to the lungs.
We are focused on a variety of innovative therapies, in different development stages from discovery to IND.